| |
4 hours before surgery |
After surgery |
t |
P |
| FBGmmol∕L |
|
|
|
|
| Placebo group |
4.93 ± 0.59 |
9.32 ± 1.31 |
13.624 |
0.000 |
| CHOD group |
5.08 ± 0.50 |
7.64 ± 0.78 |
13.918 |
0.000 |
| t |
0.746 |
5.294 |
|
|
| P |
0.392 |
0.026 |
|
|
| FINSU |
|
|
|
|
| Placebo group |
8.25 ± 1.62 |
30.72 ± 6.66 |
15.781 |
0.000 |
| CHOD group |
8.54 ± 1.89 |
16.72 ± 3.88 |
10.011 |
0.000 |
| t |
0.612 |
4.797 |
|
|
| P |
0.438 |
0.034 |
|
|
| HOMA-IR |
|
|
|
|
| Placebo group |
1.82 ± 0.45 |
12.68 ± 3.13 |
16.318 |
0.000 |
| CHOD group |
1.90 ± 0.36 |
5.67 ± 1.40 |
14.190 |
0.000 |
| t |
0.698 |
9.646 |
|
|
| P |
0.408 |
0.003 |
|
|
| ISI |
|
|
|
|
| Placebo group |
0.63 ± 0.41 |
0.41 ± 0.19 |
23.000 |
0.000 |
| CHOD group |
0.62 ± 0.31 |
0.48 ± 0.26 |
22.561 |
0.000 |
| t |
0.829 |
5.112 |
|
|
| P |
0.367 |
0.029 |
|
|
|
